ITGB3 and myocardial infarction: The double staining with anti-PKCepsilon and anti-CD61 monoclonal antibodies showed that CP patients with a final diagnosis of myocardial infarction (CP-AMI) display a significantly higher percentage of PKCe-expressing PLTs as compared to CP patients not attributable to AMI (CP-noAMI) (Fig. 1a).